Scarica l'app Stockscreener
3.63
6.92%
-0.27
Trisalus Life Sciences Inc Azioni (TLSI) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
28.18%
11.41
|
8.899 | 13.21 | 11.57 | 11.21 |
| Cost Of Revenue |
22.60%
1.508
|
1.23 | 1.762 | 1.906 | 1.802 |
| Gross Profit |
29.08%
9.899
|
7.669 | 11.44 | 9.66 | 9.411 |
| Research and Development |
2.46%
3.137
|
3.216 | - | - | - |
| Depreciation and Amortization |
0.74%
0.136
|
0.135 | 0.126 | 0.163 | 0.165 |
| Operating Income/Loss |
16.67%
-9.813
|
-8.411 | -3.271 | -9.014 | -7.332 |
| Income/Loss From Continuing Operations Before Tax |
695.14%
-9.183
|
1.543 | -9.753 | -10.81 | -8.291 |
| Income Tax Expense/Benefit |
0.00%
0.004
|
0.004 | - | 0.005 | -0.003 |
Net Income/Loss
|
696.95%
-9.187
|
1.539 | -9.753 | -10.81 | -8.288 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | 0.714 |
| Basic Average Shares |
13.11%
58.30
|
51.54 | 3.0396 | 43.06 | 32.90 |
| Diluted Average Shares |
11.44%
58.30
|
52.31 | 3.0396 | 43.06 | 32.90 |
| Basic Earnings Per Share |
633.33%
-0.16
|
0.03 | -0.12 | -0.96 | -0.27 |
| Diluted Earnings Per Share |
633.33%
-0.16
|
0.03 | -0.12 | -0.96 | -0.27 |
2.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):